Digital Health: Page 2

Baxter to buy Hillrom for $10.5B in bid to expand connected care portfolio

Wall Street analysts and investors had previously questioned the price and strategic fit of a deal, which was rumored for weeks.

By Greg Slabodkin • Sept. 02, 2021

Zimmer 'smart knee' gets FDA nod as ortho rivalry with Stryker heats up

The orthopaedics device maker, through a collaboration with Canary Medical, becomes the first company to bring an implantable smart device for total knee replacement to the U.S. market.

By Susan Kelly • Aug. 31, 2021

Baxter in late-stage talks to buy Hillrom for about $10B: WSJ

A Baird analyst said he talked himself into backing a union given Hillrom's connected care push. However, J.P. Morgan analysts argued Baxter has a "tall order" convincing investors it's a "more strategic vs. financial" acquisition.

By Greg Slabodkin • Aug. 30, 2021

Mayo Clinic, Alphabet's Verily partner to build clinical decision support tools

The two plan to initially focus on a set of cardiovascular and cardiometabolic conditions.

By Rebecca Pifer • Aug. 27, 2021

Google disbands health unit as chief departs for Cerner

The dissolution of the division is the latest rolled back initiative from a tech giant in the space.

By Rebecca Pifer • Aug. 25, 2021

Remote collaboration from the operating room: The 'new normal' for medtech

For too long, medical information sharing and collaboration has depended on in-person communication. The COVID-19 pandemic has caused us to rethink how we deliver healthcare.

By Jerry Carter, Avail Medsystems • Aug. 23, 2021

Post call: How a pandemic transformed healthcare for the future

From the frontlines of 2020 to the forefront of the future, what worked, what didn’t, and what must be prioritized today to thrive tomorrow. 

Abiomed leads latest FDA breakthrough designations for heart disease devices

The agency awarded the breakthrough privileges to Abiomed's Impella ECP, which the company contends is the world's smallest heart pump and could provide critical hemodynamic support to coronary artery disease patients.

By Nick Paul Taylor • Aug. 19, 2021

Predicting the future of healthcare: 10 takeaways from HIMSS21

Along with "guarded optimism" on the current state of the pandemic, some 19,000 on-site attendees in Las Vegas mulled what's next for AI, telehealth, cybersecurity, mental health and more.

By Rebecca Pifer , Hailey Mensik • Aug. 17, 2021

Q&A with Philips' head of connected healthcare on new products, hospital tech adoption in the COVID-19 era

Roy Jakobs caught up with Healthcare Dive virtually on the sidelines of HIMSS21 to chat about provider burden, interoperability and new products.

By Rebecca Pifer • Aug. 12, 2021

Digital therapeutics — a double-edged sword?

Aloha McBride, EY's global health leader, argues that algorithms need to be regularly audited and screened for bias and discrepancies, while clinicians play a vital role in explaining the key features of apps and patient privacy risks.

By Aloha McBride • Aug. 10, 2021

Diabetes tech companies set sights on Type 2 patients as user numbers climb

With patients flocking to CGMs and insulin pumps over the past several years, companies like Dexcom, Insulet and Tandem are looking to further expand. 

By Ricky Zipp • Aug. 09, 2021

5 must-watch panels at an unprecedented HIMSS21

Masks and proof of vaccination will be required on the ground in Las Vegas, and a corresponding digital event will also take place.

By Rebecca Pifer • Aug. 09, 2021

iRhythm doesn't expect 2022 CMS pricing. 'It may take some time.'

Amid a challenging 2021, the cardiac monitoring player beat Wall Street revenue expectations. However, Medicare pricing uncertainty is still hanging over its future.

By Ricky Zipp • Aug. 06, 2021

Digital health, heart disease devices feature in latest FDA breakthrough designations

Philips, Endologix and several smaller companies in recent weeks won the regulatory privilege, giving them speedier review of products that may provide more effective treatments for life-threatening conditions.

By Nick Paul Taylor • Aug. 02, 2021

Hillrom reverses course, will finalize $375M BardyDx acquisition

The decision ends a months-long fight by Hillrom to back out of the buy due to substantially reduced Medicare rate cuts for long-term cardiac monitoring. Hillrom expects the deal to close in the coming weeks.

By Ricky Zipp • Aug. 02, 2021

GE Healthcare's COVID-19 recovery continues with double-digit growth in imaging, ultrasound

Second-quarter results reflect the return of elective procedures to pre-pandemic levels. A standout was its pharmaceutical diagnostics business which saw orders grow nearly 50% organically year over year.   

By Greg Slabodkin • July 27, 2021

Philips Q2 hit from sleep apnea, ventilator recall overshadows pandemic recovery

CEO Frans van Houten downplayed the potential of a significant impact on Philips' business. But, Baird analysts contend the company could lose about $800 million in the 12-month repair/replace cycle, with ResMed benefiting.

By Nick Paul Taylor • July 26, 2021

Health tracking tech revenue to reach $13B this year amid sustained consumer demand

Devices like blood glucose trackers, smart thermometers and pulse oximeters are a small but growing slice of the larger consumer tech market, according to the Consumer Technology Association.

By Rebecca Pifer • July 19, 2021

Dexcom wins FDA nod for real-time APIs, allowing third-party developers access to CGM data

Teladoc Health's Livongo and smartwatch maker Garmin are in the testing and development phase, Dexcom said. The clearance comes as FDA is working to address the devices backlog created by the pandemic.

By Ricky Zipp • July 16, 2021

CMS proposes extension of Medicare telehealth coverage

Provider groups are not happy with the payment adjustment in the rule — a 3.75% reduction to the conversion factor due to budget neutrality requirements — and will likely seek congressional intervention.

By Shannon Muchmore • July 14, 2021

CMS again passes on national pricing for long-term cardiac monitoring, dramatically reduced rates remain

The Physician Fee Schedule proposal continues the seven-month pricing saga that has hung over the cardiac wearables sub-market. Companies like iRhythm now have few options left to get substantially reduced rates increased.

By Ricky Zipp • July 14, 2021

Telehealth use stabilizing at 38 times pre-COVID-19 levels, McKinsey says

Although usage has dropped slightly since its peak in spring 2020, patient and physician attitudes toward telehealth have improved, according to new data from the consultancy.

By Rebecca Pifer • July 13, 2021

Hillrom ordered to complete BardyDx transaction by Delaware court

The court found recent Medicare rate cuts for long-term cardiac wearables did not qualify as a material adverse event, siding with Bardy Diagnostics. However, the judge did not grant BardyDx compensatory damages.

By Ricky Zipp • July 12, 2021

MDUFA talks expose 'fundamentally different' views of FDA and device companies

At the latest meeting over user fees, industry remained opposed to the agency's pitch for a Total Product Life Cycle Advisory Program, which it contends would extend the scope beyond FDA's purview. 

By Nick Paul Taylor • July 12, 2021